Skip to content

Advertisement

  • Poster presentation
  • Open Access

First report of OXA-48 carbapenemase-producing Escherichia coli in Taiwan

  • 1,
  • 2,
  • 1,
  • 2,
  • 1, 3,
  • 1, 3,
  • 1, 3 and
  • 2, 3
Antimicrobial Resistance and Infection Control20154 (Suppl 1) :P126

https://doi.org/10.1186/2047-2994-4-S1-P126

  • Published:

Keywords

  • Escherichia Coli
  • Bactericidal Activity
  • Outer Membrane
  • Antimicrobial Therapy
  • Sequence Typing

Introduction

Carbapenems are the last-line antibiotic in treating Enterobacteriaceae because its broad-spectrum antibacterial ability, high bactericidal activity and good stability to β-lactamases. However, carbapenem-resistant Enterobacteriaceae (CRE) infection increased all over the world in recent years. The challenge of carbapenems in treating Enterobacteriaceae is increasing.

Objectives

A 55-year old woman who had been diagnosed with cancer and had received multiple courses of chemotherapy in Vietnam, visited our hospital for a second opinion in June 2014.

Left breast tumor with non-discharge necrotic tissue was presented at admission. The laboratory examination demonstrated WBC 6300/uL, Hb 12.1g/dL and PLT 103000/uL. Specimen from left breast wound grew Escherichia coli, which resistant to carbapenems, broad-spectrum β-lactams and fluoroquinolones. There was no inflammation reaction caused by the pathogen. During hospitalization, she did not receive antimicrobial therapy effective to the pathogen.

Methods

We found that this Escherichia coli had the presentation of carbapenemase via modified Hodge test. Polymerase chain reaction and DNA sequencing was performed to test if Carbapenemase (blaKPC, blaNDM, blaIPM, blaVIM, blaOXA) or β-lactamases (SH, TEM, OXA, GES, CTX-M) presents.

Results

Resistance genes of blaOXA-48 and CTX-M-1-group were found. Besides, this Escherichia coli also presented with loss of outer membrane protein A and F. With multilocus sequence typing (MLST) analysis, this Escherichia coli is ST-405.

Conclusion

To our knowledge, this is the first OXA-48 carbapenemase producing Escherichia coli isolated in Taiwan, though it’s originated from Vietnam. It’s resistance profile is similar to other OXA-48 carbapenemase producing Escherichia coli isolated from Japan and France. According to this finding, Escherichia coli acquiring OXA-48 carbapenemase may had spread to Southeastern Asia. In order to prevent the transmission of CRE, the detection of carbapenemase in Enterobacteriaceae is important.

Disclosure of interest

None declared.

Authors’ Affiliations

(1)
Department of Infection Control, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, Province of China
(2)
Clinical Microbiology Laboratory, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, Province of China
(3)
Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital,Kaohsiung Medical University, Kaohsiung, Taiwan, Province of China

Copyright

© Jao et al; licensee BioMed Central Ltd. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement